136 related articles for article (PubMed ID: 10187778)
1. Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation.
Li YT; Li SC; Hasegawa A; Ishida H; Kiso M; Bernardi A; Brocca P; Raimondi L; Sonnino S
J Biol Chem; 1999 Apr; 274(15):10014-8. PubMed ID: 10187778
[TBL] [Abstract][Full Text] [Related]
2. Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.
Li YT; Li SC; Kiso M; Ishida H; Mauri L; Raimondi L; Bernardi A; Sonnino S
Biochim Biophys Acta; 2008 Mar; 1780(3):353-61. PubMed ID: 17967427
[TBL] [Abstract][Full Text] [Related]
3. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
4. Design and efficient synthesis of novel GM2 analogues with respect to the elucidation of the function of GM2 activator.
Komori T; Ando T; Imamura A; Li YT; Ishida H; Kiso M
Glycoconj J; 2008 Oct; 25(7):647-61. PubMed ID: 18368480
[TBL] [Abstract][Full Text] [Related]
5. Interaction of GM2 activator protein with glycosphingolipids.
Hama Y; Li YT; Li SC
J Biol Chem; 1997 Jan; 272(5):2828-33. PubMed ID: 9006924
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the enzymatic resistance of the GM2 ganglioside.
Li YT; Li SC; Ishida H; Kiso M; Raimondi L; Bernardi A; Sonnino S
Methods Enzymol; 2003; 363():242-64. PubMed ID: 14579580
[No Abstract] [Full Text] [Related]
7. The structural basis for the susceptibility of gangliosides to enzymatic degradation.
Sonnino S; Brocca P; Acquotti D; Bernardi A; Raimondi L; Kiso M; Ishida H; Li SC; Li YT
Biosci Rep; 1999 Jun; 19(3):163-8. PubMed ID: 10513893
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an alternatively spliced GM2 activator protein, GM2A protein. An activator protein which stimulates the enzymatic hydrolysis of N-acetylneuraminic acid, but not N-acetylgalactosamine, from GM2.
Wu YY; Sonnino S; Li YT; Li SC
J Biol Chem; 1996 May; 271(18):10611-5. PubMed ID: 8631864
[TBL] [Abstract][Full Text] [Related]
9. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus).
DeGasperi R; Li SC; Li YT
J Biol Chem; 1988 Jan; 263(3):1325-8. PubMed ID: 2961751
[TBL] [Abstract][Full Text] [Related]
10. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
11. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.
Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT
J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048
[TBL] [Abstract][Full Text] [Related]
12. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
Sharma R; Bukovac S; Callahan J; Mahuran D
Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
[TBL] [Abstract][Full Text] [Related]
13. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
15. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2.
Li SC; Serizawa S; Li YT; Nakamura K; Handa S
J Biol Chem; 1984 May; 259(9):5409-10. PubMed ID: 6232275
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
17. Isolation and structural characterization of N-acetyl- and N-glycolylneuraminic-acid-containing GalNAc-GD1a isomers, IV4GalNAcIV3Neu5AcII3Neu5GcGgOse4Cer and IV4GalNAcIV3Neu5GcII3Neu5AcGgOse4Cer, from bovine brain.
Casellato R; Brocca P; Li SC; Li YT; Sonnino S
Eur J Biochem; 1995 Dec; 234(3):786-93. PubMed ID: 8575436
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
19. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a novel phytosphingosine-containing GM2 ganglioside from mullet roe (Mugil cephalus).
Li YT; Hirabayashi Y; DeGasperi R; Yu RK; Ariga T; Koerner TA; Li SC
J Biol Chem; 1984 Jul; 259(14):8980-5. PubMed ID: 6746635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
